Krsnaa Diagnostics

Krsnaa Diagnostics FCF Yield

The Free Cash Flow Yield of Krsnaa Diagnostics (KRSNAA.NS) as of Oct 31, 2026 is -4.81 %. In the previous year, Free Cash Flow Yield was -2.00 % — a change of 139.85% (lower).

FCF Yield

-4.81 %

YoY

139.85%

Last updated:

Free Cash Flow Yield of Krsnaa Diagnostics is 2026 -4.81 % . Free Cash Flow Yield of Krsnaa Diagnostics was 2025 -2.00 % . It decreases by 139.85% lower compared to the previous year.

The Krsnaa Diagnostics FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
-2.12 INR
Jan 1, 2020
-1.99 INR
Jan 1, 2021
1.82 INR
Jan 1, 2022
-0.19 INR
Jan 1, 2023
-3.32 INR
Jan 1, 2024
-8.65 INR
Jan 1, 2025
-2.00 INR
Jan 1, 2026
-4.81 INR
The Krsnaa Diagnostics FCF Yield history
YEARFCF YieldYoY
-4.81 %+139.85%
-2.00 %-76.82%
-8.65 %+160.60%
-3.32 %+1,614.33%
-0.19 %-110.62%
1.82 %-191.73%
-1.99 %-6.19%
-2.12 %-28.26%
-2.95 %-742.18%
0.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Krsnaa Diagnostics Stock analysis

What does Krsnaa Diagnostics do? Krsnaa Diagnostics Ltd provides diagnostic services across India, including radiology and pathology through X-Ray, CT scan, MRI, mammography, and tele-reporting. The company offers lab services for blood and urine investigations, supported by technology that aids healthcare professionals in diagnosing medical conditions. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS). The firm serves public and private hospitals, medical colleges, and community health centers as its primary customers. The company generates revenue through diagnostic service fees charged to hospitals, medical colleges, and community health centers. These institutions purchase the diagnostic services for their patients, utilizing Krsnaa's imaging and lab capabilities. The health packages are also sold to these institutions for patient care programs, contributing to the company's revenue streams. Krsnaa Diagnostics Ltd's product portfolio focuses on medical imaging and laboratory testing, targeting healthcare providers and institutions. The primary segments served are public and private hospitals, medical colleges, and community health centers, which rely on the company's diagnostic solutions for patient diagnostics and treatment planning. Krsnaa Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Krsnaa Diagnostics stock

Free Cash Flow Yield of Krsnaa Diagnostics is -4.81 % in 2026.

Free Cash Flow Yield of Krsnaa Diagnostics changed from -2.00 % to -4.81 %, representing a 139.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Krsnaa Diagnostics since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Krsnaa Diagnostics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Krsnaa Diagnostics

All Key Metrics — Krsnaa Diagnostics